Quality of life, self-stigma, and coping strategies in patients with neurotic spectrum disorders: a cross-sectional study.
coping strategies
neurotic spectrum disorders
quality of life
self-stigma
Journal
Psychology research and behavior management
ISSN: 1179-1578
Titre abrégé: Psychol Res Behav Manag
Pays: New Zealand
ID NLM: 101514563
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
22
2
2019
pubmed:
23
2
2019
medline:
23
2
2019
Statut:
epublish
Résumé
Modern psychiatry focuses on self-stigma, coping strategies, and quality of life (QoL). This study looked at relationships among severity of symptoms, self-stigma, demographics, coping strategies, and QoL in patients with neurotic spectrum disorders. A total of 153 clinically stable participants who met criteria for generalized anxiety disorder, social phobia, panic disorder, agoraphobia, mixed anxiety-depressive disorder, adjustment disorders, somatoform disorders, or obsessive-compulsive disorder were included in a cross-sectional study. Psychiatrists examined patients during regular psychiatric checkups. Patients completed the Quality of Life Satisfaction and Enjoyment Questionnaire (Q-LES-Q), Internalized Stigma of Mental Illness Scale (ISMI), a sociodemographic questionnaire, the Stress Coping Style Questionnaire (Strategie Zvládání Stresu [SVF] 78), and the Clinical Global Impression (CGI) scale. The diagnostic subgroups differed significantly in age and use of negative coping strategies, but not in other measured clinical or psychological variables. The findings showed that neither sex nor partnership played a role in perceived QoL. All Q-LES-Q domains correlated negatively with all ISMI domains, except school/study. Unemployed and employed groups of patients differed in QoL. Each of the coping strategies, except the need for social support, was related to self-stigma. The findings showed that sex, partnership, education, and employment played no role in self-stigma. No differences between sexes in positive coping strategies, severity of disorder, self-stigma, or QoL were found. QoL correlated significantly with all coping strategies, except for guilt denial. Multiple regression showed the most important factors to be positive coping, employment, and overall self-stigma rating, explaining 32.9% of QoL. Mediation analysis showed self-stigma level and negative coping strategies to be the most influential. The most substantial factors associated with self-stigma, as indicated by regression analysis, were Q-LES-Q total, subjective CGI, and positive coping strategies, which clarified 44.5% of the ISMI. The study confirmed associations among self-stigma, quality of life, disorder severity, and coping strategies of outpatients with neurotic spectrum disorders.
Sections du résumé
BACKGROUND
BACKGROUND
Modern psychiatry focuses on self-stigma, coping strategies, and quality of life (QoL). This study looked at relationships among severity of symptoms, self-stigma, demographics, coping strategies, and QoL in patients with neurotic spectrum disorders.
METHODS
METHODS
A total of 153 clinically stable participants who met criteria for generalized anxiety disorder, social phobia, panic disorder, agoraphobia, mixed anxiety-depressive disorder, adjustment disorders, somatoform disorders, or obsessive-compulsive disorder were included in a cross-sectional study. Psychiatrists examined patients during regular psychiatric checkups. Patients completed the Quality of Life Satisfaction and Enjoyment Questionnaire (Q-LES-Q), Internalized Stigma of Mental Illness Scale (ISMI), a sociodemographic questionnaire, the Stress Coping Style Questionnaire (Strategie Zvládání Stresu [SVF] 78), and the Clinical Global Impression (CGI) scale.
RESULTS
RESULTS
The diagnostic subgroups differed significantly in age and use of negative coping strategies, but not in other measured clinical or psychological variables. The findings showed that neither sex nor partnership played a role in perceived QoL. All Q-LES-Q domains correlated negatively with all ISMI domains, except school/study. Unemployed and employed groups of patients differed in QoL. Each of the coping strategies, except the need for social support, was related to self-stigma. The findings showed that sex, partnership, education, and employment played no role in self-stigma. No differences between sexes in positive coping strategies, severity of disorder, self-stigma, or QoL were found. QoL correlated significantly with all coping strategies, except for guilt denial. Multiple regression showed the most important factors to be positive coping, employment, and overall self-stigma rating, explaining 32.9% of QoL. Mediation analysis showed self-stigma level and negative coping strategies to be the most influential. The most substantial factors associated with self-stigma, as indicated by regression analysis, were Q-LES-Q total, subjective CGI, and positive coping strategies, which clarified 44.5% of the ISMI.
CONCLUSION
CONCLUSIONS
The study confirmed associations among self-stigma, quality of life, disorder severity, and coping strategies of outpatients with neurotic spectrum disorders.
Identifiants
pubmed: 30787642
doi: 10.2147/PRBM.S179838
pii: prbm-12-081
pmc: PMC6363490
doi:
Types de publication
Journal Article
Langues
eng
Pagination
81-95Déclaration de conflit d'intérêts
Disclosure The authors report no conflicts of interest in this work.
Références
Am J Psychiatry. 2000 May;157(5):669-82
pubmed: 10784456
Harv Rev Psychiatry. 2000 Dec;8(6):273-82
pubmed: 11133822
Am J Psychiatry. 2001 Mar;158(3):479-81
pubmed: 11229992
Soc Sci Med. 2002 Sep;55(5):823-34
pubmed: 12190273
Psychol Bull. 2003 Mar;129(2):216-269
pubmed: 12696840
Psychol Med. 2003 May;33(4):611-22
pubmed: 12785463
Eur Neuropsychopharmacol. 2003 Oct;13(5):347-54
pubmed: 12957333
Psychiatry Res. 2003 Nov 1;121(1):31-49
pubmed: 14572622
J Affect Disord. 2004 Jan;78(1):49-55
pubmed: 14672796
Annu Rev Psychol. 2004;55:745-74
pubmed: 14744233
Psychiatry Res. 2004 Dec 30;129(3):257-65
pubmed: 15661319
J Nerv Ment Dis. 2005 Mar;193(3):196-202
pubmed: 15729110
Psychiatr Serv. 2005 May;56(5):599-601
pubmed: 15872170
Qual Life Res. 2005 Sep;14(7):1693-703
pubmed: 16119181
Psychooncology. 2006 Jul;15(7):595-603
pubmed: 16287209
World Psychiatry. 2006 Oct;5(3):139-45
pubmed: 17139340
Psychiatry Res. 2007 Feb 28;150(1):71-80
pubmed: 17270279
Clin Psychol Rev. 2007 Jun;27(5):572-81
pubmed: 17343963
J Anxiety Disord. 2008 Dec;22(8):1516-22
pubmed: 18424062
Acta Psychiatr Scand. 2008 Oct;118(4):305-14
pubmed: 18754833
BMC Public Health. 2009 Feb 20;9:61
pubmed: 19228435
Schizophr Res. 2009 May;110(1-3):65-71
pubmed: 19237266
J Orthop Trauma. 2009 Aug;23(7):525-30
pubmed: 19633463
Psychiatry Res. 2010 Nov 30;180(1):10-5
pubmed: 20493552
Soc Sci Med. 2010 Dec;71(12):2150-61
pubmed: 21051128
Eur Psychiatry. 2012 Aug;27(6):422-5
pubmed: 21592736
Psychiatry Res. 2011 Oct 30;189(3):339-43
pubmed: 21715017
Qual Life Res. 2013 Mar;22(2):333-7
pubmed: 22437546
Adm Policy Ment Health. 2013 Sep;40(5):384-99
pubmed: 22833051
Clin Psychol Rev. 2013 Jul;33(5):686-697
pubmed: 23702592
Int J Ment Health Syst. 2013 Sep 03;7(1):21
pubmed: 24004512
Compr Psychiatry. 2014 Jan;55(1):221-31
pubmed: 24060237
Turk Psikiyatri Derg. 2013 Winter;24(4):231-9
pubmed: 24310089
Trauma Mon. 2012 Summer;17(2):282-6
pubmed: 24350107
J Abnorm Child Psychol. 2015 Feb;43(2):297-309
pubmed: 24993313
Health Qual Life Outcomes. 2014 Oct 29;12:152
pubmed: 25358486
Neuro Endocrinol Lett. 2014;35(6):474-80
pubmed: 25433850
Neuro Endocrinol Lett. 2014;35(7):624-32
pubmed: 25617887
Neuro Endocrinol Lett. 2014;35(8):711-7
pubmed: 25702300
Child Care Health Dev. 2015 Nov;41(6):1216-26
pubmed: 25873448
Psychiatry Res. 2015 Aug 30;228(3):752-9
pubmed: 26073284
J Pers Soc Psychol. 1989 Dec;57(6):1024-40
pubmed: 2614656
Neuropsychiatr Dis Treat. 2015 Jul 17;11:1767-79
pubmed: 26229471
Neuropsychiatr Dis Treat. 2015 Aug 18;11:2125-42
pubmed: 26316759
Dialogues Clin Neurosci. 2015 Sep;17(3):327-35
pubmed: 26487813
J Clin Child Adolesc Psychol. 2017 Sep-Oct;46(5):686-694
pubmed: 26630122
Neuropsychiatr Dis Treat. 2015 Dec 10;11:3041-8
pubmed: 26677331
Patient Prefer Adherence. 2016 Jun 24;10:1151-8
pubmed: 27445463
Neuropsychiatr Dis Treat. 2016 Jun 24;12:1539-51
pubmed: 27445474
Patient Prefer Adherence. 2016 Jul 22;10:1289-98
pubmed: 27524884
Psychiatry Res. 2016 Dec 30;246:500-506
pubmed: 27821360
Neuropsychiatr Dis Treat. 2016 Nov 24;12:3021-3030
pubmed: 27920539
Neuropsychiatr Dis Treat. 2017 Feb 23;13:567-576
pubmed: 28260904
J Behav Exp Econ. 2015 Feb;54:10-21
pubmed: 28713668
Child Adolesc Psychiatry Ment Health. 2017 Jul 20;11:33
pubmed: 28814971
Neuropsychiatr Dis Treat. 2017 Aug 03;13:2073-2083
pubmed: 28831256
Neuro Endocrinol Lett. 2017 Dec;38(6):429-426
pubmed: 29298284
Neuropsychiatr Dis Treat. 2017 Dec 22;14:73-82
pubmed: 29339924
J Pers Soc Psychol. 1984 Apr;46(4):839-52
pubmed: 6737195
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712